Is Radium Ra 223 Dichloride safe while breastfeeding?
Here is what LactMed, the Drugs and Lactation Database published by the U.S. National Institute of Child Health and Human Development (NICHD), reports about Radium Ra 223 Dichloride. The text below is quoted from that source — it is not our own verdict.
Summary of use during breastfeeding
Radium-223 dichloride is not indicated for use in women and should not be given to nursing mothers. However, if a nursing mother receives radium-223 dichloride, she should permanently discontinue nursing her current infant.[1]
Effects on the breastfed infant
Relevant published information was not found as of the revision date.
Effects on milk supply
Relevant published information was not found as of the revision date.
Levels in milk
Radium-223 has a physical half-life of 11.4 days and emits alpha particles with a decay energy of 5.979 MeV upon decay.
Source: Drugs and Lactation Database (LactMed), National Institute of Child Health and Human Development (NICHD), via NCBI Bookshelf, record “Radium Ra 223 Dichloride” (radium-223). LactMed on NCBI Bookshelf. LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Educational summary of an authoritative source — not medical advice. Never start, stop, or change a medicine while breastfeeding without confirming with your doctor.